ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

$7.90
+0.13 (+1.67%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +210.3% upside
Low Target $15.34
Average Target $24.51
High Target $36.47
Current Price $7.90
Current
$7.90
Target
$24.51
$15.34 $24.51 avg $36.47
Scenario Analysis
Bear Case
$15.34
94.2%
Low target
Base Case
$24.51
+210.3%
Avg target
Bull Case
$36.47
+361.6%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$31.35
-74.8% from high
52-Week Low
$3.76
+110.1% from low
50-Day SMA
$19.51
-59.5% vs SMA
200-Day SMA
$8.26
-4.4% vs SMA
RSI (14)
60.5
Neutral
Target vs 52W High
$24.51
-21.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%